JPWO2021034646A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021034646A5
JPWO2021034646A5 JP2022510108A JP2022510108A JPWO2021034646A5 JP WO2021034646 A5 JPWO2021034646 A5 JP WO2021034646A5 JP 2022510108 A JP2022510108 A JP 2022510108A JP 2022510108 A JP2022510108 A JP 2022510108A JP WO2021034646 A5 JPWO2021034646 A5 JP WO2021034646A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
binding molecule
nos
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022510108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545655A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/046335 external-priority patent/WO2021034646A1/en
Publication of JP2022545655A publication Critical patent/JP2022545655A/ja
Publication of JPWO2021034646A5 publication Critical patent/JPWO2021034646A5/ja
Pending legal-status Critical Current

Links

JP2022510108A 2019-08-17 2020-08-14 多量体の二重特異性抗ｃｄ１２３結合分子及びその使用 Pending JP2022545655A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962888475P 2019-08-17 2019-08-17
US62/888,475 2019-08-17
US201962888702P 2019-08-19 2019-08-19
US62/888,702 2019-08-19
PCT/US2020/046335 WO2021034646A1 (en) 2019-08-17 2020-08-14 Multimeric bispecific anti-cd123 binding molecules and uses thereof

Publications (2)

Publication Number Publication Date
JP2022545655A JP2022545655A (ja) 2022-10-28
JPWO2021034646A5 true JPWO2021034646A5 (de) 2023-06-16

Family

ID=74659605

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510108A Pending JP2022545655A (ja) 2019-08-17 2020-08-14 多量体の二重特異性抗ｃｄ１２３結合分子及びその使用

Country Status (11)

Country Link
US (1) US20220289856A1 (de)
EP (1) EP4013796A4 (de)
JP (1) JP2022545655A (de)
KR (1) KR20220045030A (de)
CN (1) CN114341179A (de)
AU (1) AU2020334882A1 (de)
BR (1) BR112022002897A2 (de)
CA (1) CA3147767A1 (de)
IL (1) IL289964A (de)
MX (1) MX2022002024A (de)
WO (1) WO2021034646A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3560954B1 (de) 2014-04-03 2021-08-04 IGM Biosciences, Inc. Modifizierte j-kette
EP3247728B1 (de) 2015-01-20 2020-04-15 IGM Biosciences, Inc. Tumornekrosefaktor-superfamilienrezeptorbindende moleküle und verwendungen davon
EP3274051A4 (de) 2015-03-25 2018-08-22 IGM Biosciences A/S Multivalente hepatitis-b-virus-antigenbindemoleküle und verwendungen davon
CN108463245A (zh) 2015-09-30 2018-08-28 Igm生物科学有限公司 具有修饰的j链的结合分子
EP3356401B1 (de) 2015-09-30 2020-06-24 IGM Biosciences, Inc. Bindungsmoleküle mit modifizierter j-kette
EP4380693A1 (de) * 2021-08-06 2024-06-12 Universität Basel Erkennbare zelloberflächenproteinvarianten zur verwendung in der zelltherapie
IL311039A (en) * 2021-09-17 2024-04-01 Adimab Llc Anti-CD3 antibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045774A (en) * 1997-01-10 2000-04-04 Epicyte Pharmaceutical Inc. J chain polypeptide targeting molecule linked to an imaging agent
EP4269441A3 (de) * 2013-08-08 2024-01-24 Cytune Pharma Il-15- und il-15r-aplha-sushi-domänenbasierte modulokine
CN107428835B (zh) * 2015-01-23 2021-11-26 赛诺菲 抗cd3抗体、抗cd123抗体和与cd3和/或cd123特异性结合的双特异性抗体
CN108463245A (zh) * 2015-09-30 2018-08-28 Igm生物科学有限公司 具有修饰的j链的结合分子
EP3356401B1 (de) * 2015-09-30 2020-06-24 IGM Biosciences, Inc. Bindungsmoleküle mit modifizierter j-kette
US20170349660A1 (en) * 2016-06-01 2017-12-07 Xencor. Inc. Bispecific antibodies that bind cd123 and cd3
CA3091144A1 (en) * 2018-03-01 2019-09-06 Igm Biosciences, Inc. Igm fc and j-chain mutations that affect igm serum half-life

Similar Documents

Publication Publication Date Title
US11524991B2 (en) PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof
JP2022177090A5 (de)
JP6702893B2 (ja) 多重特異的抗原結合タンパク質
JP6722189B2 (ja) 単量体Ｆｃドメイン
AU2016284871B2 (en) Multispecific NK engager proteins
TWI622597B (zh) 具有交叉結合區定向之雙重可變區類抗體結合蛋白
CA3131033A1 (en) Modified fc fragment, antibodies containing the same and use thereof
JP2019528683A5 (de)
JP2017536829A5 (de)
JP2019503713A (ja) ＮＫｐ４６結合タンパク質の可変領域
JP2019530640A5 (de)
WO2015197582A1 (en) Monomeric multispecific antigen binding proteins
WO2014144357A1 (en) Tetravalent bispecific antibodies
JP2020531438A5 (ja) Ｎｋｇ２ｄ、ｃｄ１６、およびｈｌａ−ｅに結合するタンパク質
US20210253736A1 (en) Heterodimeric antibodies that bind fibroblast activation protein
US20220289856A1 (en) Multimeric bispecific anti-cd123 binding molecules and uses thereof
TWI754211B (zh) 新型雙特異性cd3/cd20多肽複合物
CN113874399A (zh) 抗ror1/抗cd3双特异性结合分子
JP2024504471A (ja) Ｒｏｒ１およびｃｄ３に対する特異性を有する多重特異性抗体
EP3713959A1 (de) Multispezifische antigenbindende proteine
US20240199750A1 (en) Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging
JPWO2021034646A5 (de)
US20220119525A1 (en) Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
WO2024051804A1 (zh) 抗ilt4抗体及其医药用途
JP2022525261A (ja) ビスタ結合抗体およびその使用